Skip to main content
Yen-Michael Hsu, MD, Pathology, New York, NY, New York-Presbyterian Hospital

Yen-MichaelShengHsuMDPhD

Pathology New York, NY

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology

Assistant Professor of Pathology and Laboratory Medicine

Dr. Hsu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hsu's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Blood Banking/Transfusion Medicine, 2013 - 2014
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2010 - 2013
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 2010

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2014 - 2024
  • PA State Medical License
    PA State Medical License 2021 - 2024
  • CA State Medical License
    CA State Medical License 2013 - 2023
  • American Board of Pathology Pathology - Clinical
  • American Board of Pathology Blood Banking/Transfusion Medicine

Publications & Presentations

PubMed

Abstracts/Posters

  • Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
    Yen-Michael S. Hsu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Fli-1 Transcriptionally Integrates Microenvironmental Cues Sensing By Self-Renewing Hematopoietic Stem and Progenitor Cells
    Yen-Michael S. Hsu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare
    UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCareAugust 4th, 2021
  • UPMC, Avalon GloboCare Ink Partnership to Advance CAR T-cell Treatments
    UPMC, Avalon GloboCare Ink Partnership to Advance CAR T-cell TreatmentsAugust 2nd, 2021
  • Avalon GloboCare Corp. (NASDAQ: AVCO) Prepares Commercialization Launch of Its ACTEX Platform as Global Regenerative Therapeutics Outlook Looks Robust
    Avalon GloboCare Corp. (NASDAQ: AVCO) Prepares Commercialization Launch of Its ACTEX Platform as Global Regenerative Therapeutics Outlook Looks RobustJune 27th, 2019
  • Join now to see all

Hospital Affiliations